2.0
Sep 2, 2019
Anonymous employee
Former employee, more than 1 year
Recommend
CEO approval
Business outlook
Pros
Its technology and the fact that could compete with big players in the market.
Cons
After all new changes and mergers, no body knows who makes decision about the strategy and the future of company. BGI says something, MGI resists and says something else, Complete Genomics that is technically belongs to MGI, goes to a different direction! Company instead of focusing in competing in the market by improving the technology, good customer service and supporting the employees, now concentrates on fighting in the court against competitors hopes to win!